ITGB3 and neoplasm: Proangiogenic subtypes of BMDCs such as CD61+, Gr-1+CD11b+, VEGFR2+, and CXCR4+ in the circulating blood were analyzed in tumor-bearing mice using flow cytometry after CPA or 5-Fu treatment.